[{"address1": "301 Binney Street", "address2": "Suite 402", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 401 9975", "website": "https://www.synlogictx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Ms. Mary Beth Dooley", "age": 42, "title": "Principal Executive Officer & Principal Financial Officer", "yearBorn": 1982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 43, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James J. Collins Ph.D.", "age": 57, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jose-Carlos  Gutierrez-Ramos Ph.D.", "age": 62, "title": "Advisor", "yearBorn": 1962, "fiscalYear": 2018, "totalPay": 597133, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1546214400, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.31, "open": 1.3, "dayLow": 1.3, "dayHigh": 1.31, "regularMarketPreviousClose": 1.31, "regularMarketOpen": 1.3, "regularMarketDayLow": 1.3, "regularMarketDayHigh": 1.31, "payoutRatio": 0.0, "beta": 0.725, "forwardPE": -2.7872338, "volume": 1759, "regularMarketVolume": 1759, "averageVolume": 17560, "averageVolume10days": 5340, "averageDailyVolume10Day": 5340, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 15321890, "fiftyTwoWeekLow": 1.15, "fiftyTwoWeekHigh": 1.96, "priceToSalesTrailing12Months": 1915.2362, "fiftyDayAverage": 1.37258, "twoHundredDayAverage": 1.45867, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3538097, "profitMargins": 0.0, "floatShares": 2235477, "sharesOutstanding": 11696100, "sharesShort": 51735, "sharesShortPriorMonth": 53196, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0044, "heldPercentInsiders": 0.11788, "heldPercentInstitutions": 0.64609003, "shortRatio": 3.16, "shortPercentOfFloat": 0.013099999, "impliedSharesOutstanding": 11696100, "bookValue": 1.09, "priceToBook": 1.2018348, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -23359000, "trailingEps": -1.92, "forwardEps": -0.47, "lastSplitFactor": "1:7", "lastSplitDate": 1503878400, "enterpriseToRevenue": -442.262, "enterpriseToEbitda": 0.229, "52WeekChange": -0.24277455, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 1.31, "recommendationKey": "none", "totalCash": 18860000, "totalCashPerShare": 1.613, "ebitda": -15430000, "totalDebt": 0, "quickRatio": 2.666, "currentRatio": 2.795, "totalRevenue": 8000, "revenuePerShare": 0.001, "returnOnAssets": -0.20677, "returnOnEquity": -1.02627, "grossProfits": 8000, "freeCashflow": -25909624, "operatingCashflow": -31658000, "revenueGrowth": -1.0, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1972.125, "financialCurrency": "USD", "symbol": "SYBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Synlogic, Inc.", "longName": "Synlogic, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.31, "exchange": "NCM", "messageBoardId": "finmb_268899196", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1742403312, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1443619800000, "regularMarketChange": 0.0, "regularMarketDayRange": "1.3 - 1.31", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 17560, "fiftyTwoWeekLowChange": 0.15999997, "fiftyTwoWeekLowChangePercent": 0.13913041, "fiftyTwoWeekRange": "1.15 - 1.96", "fiftyTwoWeekHighChange": -0.6500001, "fiftyTwoWeekHighChangePercent": -0.3316327, "fiftyTwoWeekChangePercent": -24.277454, "dividendDate": 1503878400, "earningsTimestamp": 1741267800, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.92, "epsForward": -0.47, "fiftyDayAverageChange": -0.06258011, "fiftyDayAverageChangePercent": -0.04559305, "twoHundredDayAverageChange": -0.14867008, "twoHundredDayAverageChangePercent": -0.10192166, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Synlogic", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]